Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukapheresis”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Not applicableEnrolling By InvitationNCT03226704
What this trial is testing

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

Who this might be right for
LeukemiaLymphomaAcute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 120
Not applicableUnknownNCT01576237
What this trial is testing

Multinational Haemapheresis Vigilance Study

Who this might be right for
Blood Donation With Hemapheresis
DGTI - Haemapheresis Vigilance Working Party 50,000
Not applicableStudy completedNCT03517917
What this trial is testing

Prospective Tissue Collection Research Protocol

Who this might be right for
Solid Tumor
AstraZeneca 221
Testing effectiveness (Phase 2)Ended earlyNCT03709706
What this trial is testing

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Who this might be right for
Neoplasms
GlaxoSmithKline 34
Testing effectiveness (Phase 2)Ended earlyNCT03937791
What this trial is testing

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Who this might be right for
Squamous Lntraepithelial Lesions of VulvaNeoplasms, Squamous CellVulvar HSIL
National Cancer Institute (NCI) 1
Not applicableLooking for participantsNCT00067054
What this trial is testing

Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

Who this might be right for
Sample Collection
National Institute of Allergy and Infectious Diseases (NIAID) 3,000
Not applicableStudy completedNCT00333892
What this trial is testing

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

Who this might be right for
Human Immunodeficiency Virus
Canadian Immunodeficiency Research Collaborative 220
Not applicableStudy completedNCT02842112
What this trial is testing

Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hospices Civils de Lyon 123
Not applicableStudy completedNCT00059423
What this trial is testing

Natural History Study for BEN

Who this might be right for
NeutropeniaAgranulocytosisHematologic Diseases+2 more
National Heart, Lung, and Blood Institute (NHLBI) 178
Not applicableEnded earlyNCT01200823
What this trial is testing

Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples From Patients and Their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases Laboratory Research Studies

Who this might be right for
Idopathic Inflammatory/Autoimmune Syndromes
National Institute of Allergy and Infectious Diseases (NIAID) 96
Early research (Phase 1)Ended earlyNCT03168438
What this trial is testing

Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma

Who this might be right for
Neoplasms
GlaxoSmithKline 6
Post-approval studies (Phase 4)Ended earlyNCT00947674
What this trial is testing

Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Asahi Kasei Medical Co., Ltd. 52
Not applicableEnded earlyNCT00562601
What this trial is testing

LCI Apheresis to Obtain Plasma or White Blood Cells

Who this might be right for
Apheresis
National Institute of Allergy and Infectious Diseases (NIAID) 864
Early research (Phase 1)Study completedNCT00001476
What this trial is testing

Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up

Who this might be right for
Chronic Granulomatous DiseaseCommunicable Disease
National Institute of Allergy and Infectious Diseases (NIAID) 14
Early research (Phase 1)Ended earlyNCT00040651
What this trial is testing

Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients

Who this might be right for
SclerodermaSystemic Sclerosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Testing effectiveness (Phase 2)UnknownNCT02687672
What this trial is testing

Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury

Who this might be right for
Spinal Cord Injury
Stem Cells Arabia 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Early research (Phase 1)Study completedNCT03226691
What this trial is testing

Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients

Who this might be right for
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 15
Not applicableUnknownNCT03215004
What this trial is testing

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

Who this might be right for
HIV Infections
American Gene Technologies International Inc. 24
Next Page